Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10240521
[patent_doc_number] => 20150125515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'NOVEL SP-B & SP-C PEPTIDES, SYNTHETIC LUNG SURFACTANTS, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/376726
[patent_app_country] => US
[patent_app_date] => 2013-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34459
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376726
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376726 | SP-B and SP-C peptides, synthetic lung surfactants, and use thereof | Feb 10, 2013 | Issued |
Array
(
[id] => 10606505
[patent_doc_number] => 09326523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-03
[patent_title] => 'Class I and II lantibiotics from geobacillus thermodenitrificans'
[patent_app_type] => utility
[patent_app_number] => 14/377310
[patent_app_country] => US
[patent_app_date] => 2013-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 48
[patent_no_of_words] => 20651
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377310
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377310 | Class I and II lantibiotics from geobacillus thermodenitrificans | Feb 6, 2013 | Issued |
Array
(
[id] => 9055135
[patent_doc_number] => 20130252848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'CELLOMICS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 13/755079
[patent_app_country] => US
[patent_app_date] => 2013-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 137
[patent_figures_cnt] => 137
[patent_no_of_words] => 148497
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13755079
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/755079 | CELLOMICS SYSTEM | Jan 30, 2013 | Abandoned |
Array
(
[id] => 10975617
[patent_doc_number] => 20140378653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Factor XII Inhibitors for the Treatment of Neurological Inflammatory Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/374300
[patent_app_country] => US
[patent_app_date] => 2013-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13421
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374300
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374300 | Factor XII inhibitors for the treatment of neurological inflammatory disorders | Jan 30, 2013 | Issued |
Array
(
[id] => 10248394
[patent_doc_number] => 20150133390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'Identification of New Therapeutic Uses for Known Therapeutic Agents'
[patent_app_type] => utility
[patent_app_number] => 14/361668
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16738
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361668
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361668 | Identification of New Therapeutic Uses for Known Therapeutic Agents | Jan 24, 2013 | Abandoned |
Array
(
[id] => 8841079
[patent_doc_number] => 20130136707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'COMPOSITIONS FOR ENHANCING NAIL GROWTH'
[patent_app_type] => utility
[patent_app_number] => 13/746614
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26226
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746614
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746614 | Compositions for enhancing nail growth | Jan 21, 2013 | Issued |
Array
(
[id] => 9817279
[patent_doc_number] => 08927062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Method of preparing a substrate with a composition including an organoborane initiator'
[patent_app_type] => utility
[patent_app_number] => 13/740864
[patent_app_country] => US
[patent_app_date] => 2013-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 15014
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13740864
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/740864 | Method of preparing a substrate with a composition including an organoborane initiator | Jan 13, 2013 | Issued |
Array
(
[id] => 10248397
[patent_doc_number] => 20150133393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'Novel JNK Inhibitor Molecules for Treatment of Various Diseases'
[patent_app_type] => utility
[patent_app_number] => 14/367706
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 30939
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367706
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367706 | Novel JNK Inhibitor Molecules for Treatment of Various Diseases | Dec 20, 2012 | Abandoned |
Array
(
[id] => 9793293
[patent_doc_number] => 20150005237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'PEPTIDIC INHIBITOR OF SIGNAL TRANSMISSION FROM G-ALPHA-S TO G-ALPHA-I-COUPLED RECEPTOR CASCADES'
[patent_app_type] => utility
[patent_app_number] => 14/366874
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14366874
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/366874 | PEPTIDIC INHIBITOR OF SIGNAL TRANSMISSION FROM G-ALPHA-S TO G-ALPHA-I-COUPLED RECEPTOR CASCADES | Dec 4, 2012 | Abandoned |
Array
(
[id] => 10906387
[patent_doc_number] => 20140309400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Dry Eye Syndrome'
[patent_app_type] => utility
[patent_app_number] => 14/361529
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21125
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361529
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361529 | Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Dry Eye Syndrome | Nov 29, 2012 | Abandoned |
Array
(
[id] => 10911646
[patent_doc_number] => 20140314663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'PEPTIDE-MEDIATED DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER'
[patent_app_type] => utility
[patent_app_number] => 14/361190
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13554
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361190 | PEPTIDE-MEDIATED DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER | Nov 28, 2012 | Abandoned |
Array
(
[id] => 9799516
[patent_doc_number] => 20150011460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'ALPHA 1-PROTEINASE INHIBITOR FOR DELAYING THE ONSET OR PROGRESSION OF PULMONARY EXACERBATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/369662
[patent_app_country] => US
[patent_app_date] => 2012-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16019
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369662
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/369662 | Alpha 1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations | Nov 21, 2012 | Issued |
Array
(
[id] => 10906280
[patent_doc_number] => 20140309292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'Mutations of Histone Proteins Associated with Proliferative Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/359900
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 36132
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359900
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/359900 | Mutations of histone proteins associated with proliferative disorders | Nov 20, 2012 | Issued |
Array
(
[id] => 10273915
[patent_doc_number] => 20150158912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'TREATMENT OF IL-17 MEDIATED DISEASE BY BLOCKING SEFIR-SEFIR INTERACTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/354608
[patent_app_country] => US
[patent_app_date] => 2012-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17827
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354608
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354608 | Treatment of IL-17 mediated disease by blocking SEFIR-SEFIR interactions | Oct 28, 2012 | Issued |
Array
(
[id] => 8854090
[patent_doc_number] => 20130143766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'HIGH THROUGHPUT SCREENING OF ION CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 13/662190
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10435
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13662190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/662190 | High throughput screening of ion channels | Oct 25, 2012 | Issued |
Array
(
[id] => 9792193
[patent_doc_number] => 20150004137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'NOVEL FORMS OF PLANT DEFENSINS'
[patent_app_type] => utility
[patent_app_number] => 14/352380
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 27301
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352380
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352380 | NOVEL FORMS OF PLANT DEFENSINS | Oct 18, 2012 | Abandoned |
Array
(
[id] => 11799631
[patent_doc_number] => 09540423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Plant defensins and use in the treatment of proliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 14/352360
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14963
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352360
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352360 | Plant defensins and use in the treatment of proliferative diseases | Oct 18, 2012 | Issued |
Array
(
[id] => 8680227
[patent_doc_number] => 20130048511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'HIGH THROUGHPUT SCREENING OF ION CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 13/654936
[patent_app_country] => US
[patent_app_date] => 2012-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11151
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13654936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/654936 | High throughput screening of ion channels | Oct 17, 2012 | Issued |
Array
(
[id] => 12469521
[patent_doc_number] => 09988422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Aromatic-cationic peptides and methods for using same
[patent_app_type] => utility
[patent_app_number] => 14/347998
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26853
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/347998 | Aromatic-cationic peptides and methods for using same | Sep 27, 2012 | Issued |
Array
(
[id] => 8660019
[patent_doc_number] => 20130040848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'Methods and Devices for Detecting Structural Changes in a Molecule Measuring Electrochemical Impedance'
[patent_app_type] => utility
[patent_app_number] => 13/630391
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14292
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630391
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/630391 | Methods and devices for detecting structural changes in a molecule measuring electrochemical impedance | Sep 27, 2012 | Issued |